FDA Eyes Second Covid-19 Booster Shot

“U.S. health regulators are looking at potentially authorizing a fourth dose of a Covid-19 vaccine in the fall,“ the Wall Street Journal reports.

“The planning is still in early stages, and authorization would depend on ongoing studies establishing that a fourth dose would shore up people’s molecular defenses that waned after their first booster and reduce their risk of symptomatic and severe disease.”